avalere health topco limited
avalere health topco limited Company Information
Company Number
12357729
Next Accounts
Dec 2025
Shareholders
be vi nominees limited
david ormesher
View AllGroup Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
the featherstone building, 66 city road, london, EC1Y 2AL
Website
fishawack.comavalere health topco limited Estimated Valuation
Pomanda estimates the enterprise value of AVALERE HEALTH TOPCO LIMITED at £674.1m based on a Turnover of £312.7m and 2.16x industry multiple (adjusted for size and gross margin).
avalere health topco limited Estimated Valuation
Pomanda estimates the enterprise value of AVALERE HEALTH TOPCO LIMITED at £380.3m based on an EBITDA of £42.2m and a 9.01x industry multiple (adjusted for size and gross margin).
avalere health topco limited Estimated Valuation
Pomanda estimates the enterprise value of AVALERE HEALTH TOPCO LIMITED at £0 based on Net Assets of £-376.8m and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Avalere Health Topco Limited Overview
Avalere Health Topco Limited is a live company located in london, EC1Y 2AL with a Companies House number of 12357729. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in December 2019, it's largest shareholder is be vi nominees limited with a 81.7% stake. Avalere Health Topco Limited is a young, mega sized company, Pomanda has estimated its turnover at £312.7m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Avalere Health Topco Limited Health Check
Pomanda's financial health check has awarded Avalere Health Topco Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
5 Weak
Size
annual sales of £312.7m, make it larger than the average company (£19.1m)
£312.7m - Avalere Health Topco Limited
£19.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 39%, show it is growing at a faster rate (11.7%)
39% - Avalere Health Topco Limited
11.7% - Industry AVG
Production
with a gross margin of 28%, this company has a comparable cost of product (34.8%)
28% - Avalere Health Topco Limited
34.8% - Industry AVG
Profitability
an operating margin of -15.2% make it less profitable than the average company (4.6%)
-15.2% - Avalere Health Topco Limited
4.6% - Industry AVG
Employees
with 1639 employees, this is above the industry average (105)
1639 - Avalere Health Topco Limited
105 - Industry AVG
Pay Structure
on an average salary of £96.3k, the company has a higher pay structure (£44.5k)
£96.3k - Avalere Health Topco Limited
£44.5k - Industry AVG
Efficiency
resulting in sales per employee of £190.8k, this is equally as efficient (£190.7k)
£190.8k - Avalere Health Topco Limited
£190.7k - Industry AVG
Debtor Days
it gets paid by customers after 48 days, this is near the average (45 days)
48 days - Avalere Health Topco Limited
45 days - Industry AVG
Creditor Days
its suppliers are paid after 7 days, this is quicker than average (43 days)
7 days - Avalere Health Topco Limited
43 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Avalere Health Topco Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (14 weeks)
7 weeks - Avalere Health Topco Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 220%, this is a higher level of debt than the average (68.7%)
220% - Avalere Health Topco Limited
68.7% - Industry AVG
AVALERE HEALTH TOPCO LIMITED financials
Avalere Health Topco Limited's latest turnover from March 2024 is £312.7 million and the company has net assets of -£376.8 million. According to their latest financial statements, Avalere Health Topco Limited has 1,639 employees and maintains cash reserves of £9.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|
| Turnover | 312,698,534 | 290,027,622 | 226,932,178 | 116,653,340 |
| Other Income Or Grants | ||||
| Cost Of Sales | 225,239,776 | 202,302,616 | 150,928,179 | 75,229,338 |
| Gross Profit | 87,458,759 | 87,725,006 | 76,003,999 | 41,424,002 |
| Admin Expenses | 134,886,059 | 334,094,223 | 91,530,578 | 53,611,252 |
| Operating Profit | -47,427,300 | -246,369,217 | -15,526,579 | -12,187,250 |
| Interest Payable | 75,478,401 | 69,054,707 | 40,099,983 | 27,281,384 |
| Interest Receivable | 10,741 | 6,293,255 | 5,001,666 | 1,376,753 |
| Pre-Tax Profit | -122,894,959 | -309,130,668 | -50,405,766 | -37,837,465 |
| Tax | 4,526,970 | -5,924,960 | -2,009,665 | -1,769,281 |
| Profit After Tax | -118,367,989 | -315,055,628 | -52,415,431 | -39,606,746 |
| Dividends Paid | ||||
| Retained Profit | -118,367,989 | -315,055,628 | -52,415,431 | -39,606,746 |
| Employee Costs | 157,779,483 | 141,366,531 | 123,964,339 | 70,224,613 |
| Number Of Employees | 1,639 | 1,508 | 1,238 | 824 |
| EBITDA* | 42,211,310 | 28,394,076 | 27,642,893 | 12,829,105 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|
| Tangible Assets | 3,267,858 | 4,177,856 | 2,697,050 | 1,861,597 |
| Intangible Assets | 208,494,591 | 291,990,332 | 363,903,516 | 289,626,372 |
| Investments & Other | 23,018 | 23,018 | 24,996 | 2,942,502 |
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | 211,785,468 | 296,191,207 | 366,625,562 | 294,430,472 |
| Stock & work in progress | ||||
| Trade Debtors | 41,916,673 | 36,430,599 | 31,138,977 | 22,242,495 |
| Group Debtors | ||||
| Misc Debtors | 50,574,695 | 40,842,476 | 36,738,876 | 18,328,850 |
| Cash | 9,769,048 | 39,843,474 | 28,962,673 | 31,695,137 |
| misc current assets | ||||
| total current assets | 102,260,416 | 117,116,550 | 96,840,527 | 72,266,483 |
| total assets | 314,045,884 | 413,307,757 | 463,466,089 | 366,696,954 |
| Bank overdraft | 1 | 1 | 1 | 1 |
| Bank loan | 12,311,056 | 14,038,977 | 7,650,391 | 6,983,353 |
| Trade Creditors | 4,688,099 | 4,464,820 | 3,205,299 | 2,737,515 |
| Group/Directors Accounts | ||||
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | 54,279,137 | 68,225,274 | 58,739,376 | 26,964,454 |
| total current liabilities | 71,278,294 | 86,729,072 | 69,595,067 | 36,685,324 |
| loans | 615,341,824 | 719,917,900 | 459,912,514 | 338,860,943 |
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | 4,258,420 | |||
| provisions | ||||
| total long term liabilities | 619,600,246 | 719,917,901 | 459,912,515 | 338,860,944 |
| total liabilities | 690,878,539 | 806,646,973 | 529,507,582 | 375,546,267 |
| net assets | -376,832,656 | -393,339,216 | -66,041,493 | -8,849,313 |
| total shareholders funds | -376,832,656 | -393,339,216 | -66,041,493 | -8,849,313 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | -47,427,300 | -246,369,217 | -15,526,579 | -12,187,250 |
| Depreciation | 1,411,034 | 1,618,200 | 1,184,803 | 689,831 |
| Amortisation | 88,227,576 | 273,145,093 | 41,984,669 | 24,326,524 |
| Tax | 4,526,970 | -5,924,960 | -2,009,665 | -1,769,281 |
| Stock | ||||
| Debtors | 15,218,292 | 9,395,223 | 27,306,508 | 40,571,345 |
| Creditors | 223,279 | 1,259,521 | 467,784 | 2,737,515 |
| Accruals and Deferred Income | -13,946,137 | 9,485,898 | 31,774,922 | 26,964,454 |
| Deferred Taxes & Provisions | ||||
| Cash flow from operations | 17,797,130 | 23,819,312 | 30,569,426 | 190,448 |
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | -1,977 | -2,917,506 | 2,942,502 | |
| cash flow from investments | 1,977 | 2,917,506 | -2,942,502 | |
| Financing Activities | ||||
| Bank loans | -1,727,921 | 6,388,586 | 667,038 | 6,983,353 |
| Group/Directors Accounts | ||||
| Other Short Term Loans | ||||
| Long term loans | -104,576,076 | 260,005,386 | 121,051,571 | 338,860,943 |
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | 4,258,420 | |||
| share issue | ||||
| interest | -75,467,660 | -62,761,452 | -35,098,317 | -25,904,631 |
| cash flow from financing | -42,638,688 | 191,390,425 | 81,843,543 | 350,697,098 |
| cash and cash equivalents | ||||
| cash | -30,074,426 | 10,880,801 | -2,732,464 | 31,695,137 |
| overdraft | 1 | |||
| change in cash | -30,074,426 | 10,880,801 | -2,732,464 | 31,695,136 |
avalere health topco limited Credit Report and Business Information
Avalere Health Topco Limited Competitor Analysis
Perform a competitor analysis for avalere health topco limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mega companies, companies in EC1Y area or any other competitors across 12 key performance metrics.
avalere health topco limited Ownership
AVALERE HEALTH TOPCO LIMITED group structure
Avalere Health Topco Limited has 2 subsidiary companies.
Ultimate parent company
AVALERE HEALTH TOPCO LIMITED
12357729
2 subsidiaries
avalere health topco limited directors
Avalere Health Topco Limited currently has 11 directors. The longest serving directors include Mr Jamie Wyatt (Dec 2019) and Mrs Gail Flockhart (Mar 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jamie Wyatt | 53 years | Dec 2019 | - | Director | |
| Mrs Gail Flockhart | United Kingdom | 60 years | Mar 2020 | - | Director |
| Mrs Gail Flockhart | England | 60 years | Mar 2020 | - | Director |
| Mr Dominic Miller | England | 54 years | Mar 2020 | - | Director |
| Mr Oliver Dennis | England | 53 years | Mar 2020 | - | Director |
| Mr Peter Petrov | England | 42 years | Oct 2020 | - | Director |
| Mr Brendan Ferretti | England | 45 years | Jun 2022 | - | Director |
| Mrs Harriet Shurville | United Kingdom | 38 years | Jan 2024 | - | Director |
| Mr John Gransee | United Kingdom | 59 years | Jan 2024 | - | Director |
| Amar Urhekar | United Kingdom | 50 years | Jan 2024 | - | Director |
P&L
March 2024turnover
312.7m
+8%
operating profit
-47.4m
-81%
gross margin
28%
-7.53%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
-376.8m
-0.04%
total assets
314m
-0.24%
cash
9.8m
-0.75%
net assets
Total assets minus all liabilities
avalere health topco limited company details
company number
12357729
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
December 2019
age
6
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
March 2024
previous names
fishawack health topco limited (August 2024)
commercial services topco limited (May 2020)
accountant
-
auditor
FORVIS MAZARS LLP
address
the featherstone building, 66 city road, london, EC1Y 2AL
Bank
-
Legal Advisor
-
avalere health topco limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to avalere health topco limited.
avalere health topco limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AVALERE HEALTH TOPCO LIMITED. This can take several minutes, an email will notify you when this has completed.
avalere health topco limited Companies House Filings - See Documents
| date | description | view/download |
|---|
